| Business Name: |
Churukian Talene M DO |
| Contact Person: |
Talene Churukian |
| Address: |
630 South Raymond Avenue Unit 330, Pasadena, California 91105 |
| Phone Number: |
(626) 793-8194 |
| Annual Revenue (USD): |
$1.000.000 to $2.499.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Denham Wendy M MD - Pasadena, CA 91105
Burdumy Theodore MD - Pasadena, CA 91105
Luna James D MD - Pasadena, CA 91105
Mikhail Asbasia A MD - Pasadena, CA 91105
Maleeva Tatiana MD - Pasadena, CA 91105
Riffenburgh Stephen MD - Pasadena, CA 91105
Desanto Joseph A MD - Pasadena, CA 91105
Der Tina Carol MD - Pasadena, CA 91105
Smith Giovanni M MD - Pasadena, CA 91105
Kallal Susan M MD - Pasadena, CA 91105
Miguel John MD - Pasadena, CA 91105
Rao Vyshali S MD - Pasadena, CA 91105
Shu Theodore MD - Pasadena, CA 91105
Lu Danielle W MD - Pasadena, CA 91105
Hart Matthew MD - Pasadena, CA 91105
Perera Shanika D MD - Pasadena, CA 91105
Kim Leonard MD - Pasadena, CA 91105
Murakami Susan S MD - Pasadena, CA 91105
Enriquez-Pulid MA C MD - Pasadena, CA 91105
Heller Stephanie MD - Pasadena, CA 91105
|
The company Churukian Talene M DO provides B2C services in the form of Doctors from its single location in California.
1 to 4 employees work for Churukian Talene M DO, and the business now earns $1.000.000 to $2.499.999 per annum.
Churukian Talene M DO was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Churukian Talene M DO, please call Talene Churukian with the phone number (626) 793-8194 or visit its single location at 630 South Raymond Avenue Unit 330 in Pasadena, California 91105.
The location of the single location can also be found using the coordinates 34.13502,-118.14872.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.